Arkis CerebroFloTM EVD Catheter with Endexo®Technology
The CerebroFlo™ EVD Catheter from Arkis BioSciences is the first and only External Ventricular Drainage catheter with Endexo® Technology, a permanent additive that functionalizes all surfaces, including cut perforations, that greatly reduces fibrinogen and platelet activation and adhesion, resulting in less thrombus formation. Endexo® is a permanent and non-eluting additive extruded into the catheter material, contains no heparin, and remains throughout the life of the catheter without depleting. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in-vitro, compared to a market leading EVD catheter. The Endexo® macromolecule has been commercially shown in vascular access, dialysis, and other applications to significantly reduce thrombus related obstructions in a variety of catheters.*
*Data on file, or please reference the CerebroFlo white paper.